Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recent Advances. Neurology.

Literature DB >> 10435961

Recent Advances. Neurology.

A J Larner¹, S F Farmer.

Abstract

Mesh：

Year: 1999 PMID： 10435961 PMCID： PMC1126989 DOI： 10.1136/bmj.319.7206.362

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

40 in total

1. Guideline may help in prescribing vigabatrin.

Authors: R E Appleton
Journal: BMJ Date: 1998-11-07

2. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.

Authors:
Journal: Neurology Date: 1995-07 Impact factor: 9.910

3. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group.

Authors: K P Johnson; B R Brooks; J A Cohen; C C Ford; J Goldstein; R P Lisak; L W Myers; H S Panitch; J W Rose; R B Schiffer
Journal: Neurology Date: 1995-07 Impact factor: 9.910

4. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.

Authors:
Journal: Lancet Date: 1998-11-07 Impact factor: 79.321

5. Carotid endarterectomy for asymptomatic carotid stenosis: a meta-analysis.

Authors: O Benavente; D Moher; B Pham
Journal: BMJ Date: 1998-11-28

6. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.

Authors:
Journal: Neurology Date: 1994-11 Impact factor: 9.910

7. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation.

Authors: P Limousin; P Pollak; A Benazzouz; D Hoffmann; J F Le Bas; E Broussolle; J E Perret; A L Benabid
Journal: Lancet Date: 1995-01-14 Impact factor: 79.321

8. Remission of epilepsy: results from the National General Practice Study of Epilepsy.

Authors: O C Cockerell; A L Johnson; J W Sander; Y M Hart; S D Shorvon
Journal: Lancet Date: 1995-07-15 Impact factor: 79.321

9. Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre.

Authors: L Nashef; D R Fish; J W Sander; S D Shorvon
Journal: J Neurol Neurosurg Psychiatry Date: 1995-04 Impact factor: 10.154

10. High resolution magnetic resonance imaging in adults with partial or secondary generalised epilepsy attending a tertiary referral unit.

Authors: L M Li; D R Fish; S M Sisodiya; S D Shorvon; N Alsanjari; J M Stevens
Journal: J Neurol Neurosurg Psychiatry Date: 1995-10 Impact factor: 10.154

8 in total

Recent Advances. Neurology.

1. Guideline may help in prescribing vigabatrin.

2. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.

3. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group.

4. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.

5. Carotid endarterectomy for asymptomatic carotid stenosis: a meta-analysis.

6. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.

7. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation.

8. Remission of epilepsy: results from the National General Practice Study of Epilepsy.

9. Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre.

10. High resolution magnetic resonance imaging in adults with partial or secondary generalised epilepsy attending a tertiary referral unit.

Review 1. Neurovascular emergencies: imaging diagnosis and neurointerventional treatment.

Review 2. Mitoxantrone: a review of its use in multiple sclerosis.

3. Interest in neurology during medical clerkship in three Nigerian medical schools.

4. The neurologist in the emergency department. An Italian nationwide epidemiological survey.

5. The urgent neurological consultation in the population of the province of Ferrara, Italy.

6. The role of emergency neurology in Italy: outcome of a consensus meeting for a Intersociety position.

7. Neurophobia and its implications: evidence from a Caribbean medical school.

8. Neurophobia among medical students and non-specialist doctors in Sri Lanka.